What Rite Aid’s collapse reveals about the challenges of pharmacy retail

Since filing for bankruptcy last week, pharmaceutical retail chain Rite Aid has received interim approval to access up to US$3.45 billion in debtor-in-possession financing and continue delivering healthcare products and services and to continue paying its vendors, employees, and suppliers. However, the company has raised concerns about its ability to remain in business after it said in a regulatory filing on Wednesday that its ability to continue is dependent on successfully emerging from its Ch

This content is for IR Pro subscribers only.

Subscribe now to unlock an all-access pass.

IR Pro - monthly

$5 +GST for the first 30 days. (Auto renews at $28+GST per month.)
  • Unlimited news access
  • Exclusive members only masterclasses (live and on-demand)
  • Weekly careers advice
  • Weekly and quarterly digital magazines delivered to your inbox
Subscribe now
Retailer’s choice

IR Pro - annual

$312 +GST per year. (Auto renews annually.)
  • Unlimited news access
  • Exclusive members only masterclasses (live and on-demand)
  • Weekly careers advice
  • Weekly and quarterly digital magazines delivered to your inbox
Subscribe now